Screener
Capricor Therapeutics CAPR Pre-Tax Income
Pre-Tax Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| REVENUE / TOTAL REVENUE | Three Months Ended March 31, 2026 / — | Three Months Ended March 31, 2025 / — |
|---|---|---|
| Investment income | 2,904,506 | 729,542 |
| Loss on disposal of fixed assets | (81,143) | (150,673) |
| TOTAL OTHER INCOME (EXPENSE) | 2,831,508 | 591,354 |
| LOSS BEFORE INCOME TAXES | (33,941,345) | (24,391,594) |
| (Provision for) benefit from income taxes | — | — |
| NET LOSS | $(33,941,345) | $(24,391,594) |
| OTHER COMPREHENSIVE INCOME (LOSS) | ||
| Net unrealized gain (loss) on marketable securities | (536,881) | 784,972 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's pre-tax income?
- Capricor Therapeutics (CAPR) reported pre-tax income of -$33.94M in Q1 2026.
- How has Capricor Therapeutics's pre-tax income changed year-over-year?
- Capricor Therapeutics's pre-tax income decreased by 39.2% year-over-year, from -$24.39M to -$33.94M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Capricor Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude